Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-27 4:21 pm Purchase |
2025-03-20 | 13G | LENZ Therapeutics, Inc. LENZ |
Paradigm BioCapital Advisors LP | 1,419,832 5.200% |
1,419,832 (New Position) |
Filing History |
| 2024-11-14 4:00 pm Purchase |
2024-09-30 | 13G | LENZ Therapeutics, Inc. LENZ |
TANG CAPITAL MANAGEMENT LLC | 766,940 2.800% |
766,940 (New Position) |
Filing History |
| 2024-11-08 5:08 pm Unchanged |
2024-08-14 | 13D | LENZ Therapeutics, Inc. LENZ |
Versant Venture Capital VI, L.P. | 2,101,199 7.600% |
0 (Unchanged) |
Filing History |
| 2024-07-29 4:12 pm Purchase |
2024-07-17 | 13G | LENZ Therapeutics, Inc. LENZ |
Ridgeback Capital Investments L.P. | 1,951,875 7.200% |
1,951,875 (New Position) |
Filing History |
| 2024-04-08 2:46 pm Purchase |
2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ |
EcoR1 Capital LLC | 1,219,774 4.800% |
1,219,774 (New Position) |
Filing History |
| 2024-03-28 4:30 pm Purchase |
2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ |
Alpha Wave Ventures GP Ltd | 3,612,211 14.100% |
3,612,211 (New Position) |
Filing History |
| 2024-03-28 4:16 pm Purchase |
2024-03-21 | 13D | LENZ Therapeutics, Inc. LENZ |
RA Capital Management, L.P. | 4,250,856 16.600% |
4,250,856 (New Position) |
Filing History |
| 2024-03-25 8:42 pm Purchase |
2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ |
Samsara BioCapital, L.P. | 1,213,865 4.800% |
1,213,865 (New Position) |
Filing History |
| 2024-03-25 4:43 pm Purchase |
2024-03-21 | 13D | LENZ Therapeutics, Inc. LENZ |
Versant Venture Capital VI, L.P. | 2,101,199 8.200% |
2,101,199 (New Position) |
Filing History |
| 2024-03-25 4:33 pm Purchase |
2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ |
Point72 Asset Management, L.P. | 1,882,693 7.400% |
1,882,693 (New Position) |
Filing History |
| 2024-02-05 4:48 pm Purchase |
2024-01-24 | 13G | Graphite Bio, Inc. GRPH |
TANG CAPITAL PARTNERS LP | 445,406 5.400% |
445,406 (New Position) |
Filing History |
| 2024-02-05 4:31 pm Purchase |
2023-12-31 | 13G | Graphite Bio, Inc. GRPH |
Porteus Matthew | 506,933 6.100% |
2,857 (+0.57%) |
Filing History |
| 2023-11-17 4:38 pm Unchanged |
2023-11-14 | 13D | Graphite Bio, Inc. GRPH |
Versant Venture Capital VI, L.P. | 2,101,200 25.400% |
0 (Unchanged) |
Filing History |
| 2023-02-14 5:07 pm Purchase |
2022-12-31 | 13G | Graphite Bio, Inc. GRPH |
Samsara BioCapital, L.P. | 1,213,867 14.600% |
92,162 (+8.22%) |
Filing History |
| 2023-01-09 4:26 pm Purchase |
2023-01-06 | 13G | Graphite Bio, Inc. GRPH |
EcoR1 Capital LLC | 1,219,778 14.700% |
403,764 (+49.48%) |
Filing History |
| 2022-12-12 08:41 am Sale |
2022-12-09 | 13G | Graphite Bio, Inc. GRPH |
FMR CORP | 239,049 2.877% |
-653,478 (-73.22%) |
Filing History |
| 2022-11-18 1:40 pm Purchase |
2022-11-11 | 13G | Graphite Bio, Inc. GRPH |
EcoR1 Capital LLC | 816,014 9.800% |
816,014 (New Position) |
Filing History |
| 2022-02-14 4:19 pm Purchase |
2021-12-31 | 13G | Graphite Bio, Inc. GRPH |
Porteus Matthew | 504,076 6.100% |
504,076 (New Position) |
Filing History |
| 2022-02-14 06:06 am Purchase |
2021-12-31 | 13G | Graphite Bio, Inc. GRPH |
Samsara BioCapital, L.P. | 1,121,705 13.500% |
60,044 (+5.66%) |
Filing History |
| 2022-02-09 09:19 am Sale |
2022-02-08 | 13G | Graphite Bio, Inc. GRPH |
FMR CORP | 892,527 10.757% |
-274 (-0.03%) |
Filing History |